These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 10102793)
1. Endogenous mouse interleukin-10 is up-regulated by exogenously administered recombinant human interleukin-10, but does not contribute to the efficacy of the human protein in mouse models of endotoxemia. Smith SR; Terminelli C; Denhardt G; Manfra D; Davies L; Narula S Immunopharmacology; 1999 Feb; 41(2):119-30. PubMed ID: 10102793 [TBL] [Abstract][Full Text] [Related]
2. The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia. Smith SR; Terminelli C; Kenworthy-Bott L; Calzetta A; Donkin J J Leukoc Biol; 1994 Jun; 55(6):711-8. PubMed ID: 8195696 [TBL] [Abstract][Full Text] [Related]
3. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality. Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527 [TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum. Smith SR; Calzetta A; Bankowski J; Kenworthy-Bott L; Terminelli C J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of interleukin-6 in lipopolysaccharide (LPS)-induced experimental endotoxemia are linked to alteration in hepatic anti-oxidant enzymes and endogenous cytokines. Nandi D; Mishra MK; Basu A; Bishayi B Immunobiology; 2010 Jun; 215(6):443-51. PubMed ID: 19773091 [TBL] [Abstract][Full Text] [Related]
7. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074 [TBL] [Abstract][Full Text] [Related]
8. Effects of IL-18 and IL-10 pre-treatment on the alteration of endogenous cytokines in liver and spleen of mice with experimental endotoxemia. Nandi D; Mishra MK; Basu A; Bishayi B Indian J Exp Biol; 2010 Nov; 48(11):1103-10. PubMed ID: 21117450 [TBL] [Abstract][Full Text] [Related]
9. Effects of endotoxin tolerance on Propionibacterium acnes-primed lipopolysaccharide hepatic injury. Margenthaler JA; Landeros K; Kataoka M; Eilers M; Ku G; Flye MW J Surg Res; 2003 Jun; 112(1):102-10. PubMed ID: 12873441 [TBL] [Abstract][Full Text] [Related]
10. Elevated levels of NO in both unchallenged and LPS-challenged C. parvum-primed mice are attributable to the activity of a cytokine-inducible isoform of iNOS. Smith SR; Manfra D; Davies L; Terminelli C; Denhardt G; Donkin J J Leukoc Biol; 1997 Jan; 61(1):24-32. PubMed ID: 9000533 [TBL] [Abstract][Full Text] [Related]
11. Protective effect of tumor necrosis factor-alpha against subsequent endotoxemia in mice is mediated, in part, by interleukin-10. Murphey ED; Traber DL Crit Care Med; 2001 Sep; 29(9):1761-6. PubMed ID: 11546981 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. Bozza M; Bliss JL; Dorner AJ; Trepicchio WL J Interferon Cytokine Res; 2001 Jan; 21(1):21-30. PubMed ID: 11177577 [TBL] [Abstract][Full Text] [Related]
13. Pyrrolidine dithiocarbamate augments IL-10, inhibits TNF-alpha, MIP-1alpha, IL-12, and nitric oxide production and protects from the lethal effect of endotoxin. Németh ZH; Haskó G; Vizi ES Shock; 1998 Jul; 10(1):49-53. PubMed ID: 9688091 [TBL] [Abstract][Full Text] [Related]
14. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. Standiford TJ; Strieter RM; Lukacs NW; Kunkel SL J Immunol; 1995 Aug; 155(4):2222-9. PubMed ID: 7636269 [TBL] [Abstract][Full Text] [Related]
15. The resistance of P. acnes--primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury. Shimizu Y; Margenthaler JA; Landeros K; Otomo N; Doherty G; Flye MW Hepatology; 2002 Apr; 35(4):805-14. PubMed ID: 11915026 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. Trepicchio WL; Bozza M; Pedneault G; Dorner AJ J Immunol; 1996 Oct; 157(8):3627-34. PubMed ID: 8871663 [TBL] [Abstract][Full Text] [Related]
17. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688 [TBL] [Abstract][Full Text] [Related]
18. Proinflammatory effects of IL-10 during human endotoxemia. Lauw FN; Pajkrt D; Hack CE; Kurimoto M; van Deventer SJ; van der Poll T J Immunol; 2000 Sep; 165(5):2783-9. PubMed ID: 10946310 [TBL] [Abstract][Full Text] [Related]
19. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. Muchamuel T; Menon S; Pisacane P; Howard MC; Cockayne DA J Immunol; 1997 Mar; 158(6):2898-903. PubMed ID: 9058827 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of the endotoxemia and endotoxin tolerance on the production of Th cytokines and macrophage interleukin-6: differential regulation of indomethacin. Chae BS Arch Pharm Res; 2002 Dec; 25(6):910-6. PubMed ID: 12510847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]